Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/189423
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergeticsin resistant HL-60 cells |
Autor: | Li-Pin Kao; Morad, Samy A.F.; Davis, Traci S.; MacDougall, Matthew R.; Kassai, Miki; Abdelmageed, Noha; Fox, Todd E.; Kester, Mark; Loughran Jr. Thomas P.; Abad, José Luis CSIC ORCID ; Fabriàs, Gemma CSIC ORCID ; Faith, David J.; Su-Fern Tan; Claxton, David F.; Spiegel, Sarah; Fisher-Wellman, Kelsey H.; Cabot, Myles C. | Palabras clave: | Ceramide Sphingolipids Drug resistance Cancer |
Fecha de publicación: | jul-2019 | Editor: | American Society for Biochemistry and Molecular Biology | Citación: | Journal of Lipid Research 2019 | Resumen: | Abstract The combination of daunorubicin (dnr) and cytarabine (Ara-C) is a cornerstone of treatment for acute myelogenous leukemia (AML); resistance to these drugs is a major cause of treatment failure. Ceramide, a sphingolipid (SL), plays a critical role in cancer cell apoptosis in response to chemotherapy. Here, we investigated the effects of chemotherapy selection pressure with Ara-C and dnr on SL composition and enzyme activity in the AML cell line HL-60. Resistant cells, those selected for growth in Ara-C- and dnr-containing medium (HL-60/Ara-C and HL-60/dnr, respectively), demonstrated upregulated expression and activity of glucosylceramide synthase, acid ceramidase (AC), and sphingosine kinase 1 (SPHK1); were more resistant to ceramide than parental cells; and displayed sensitivity to inhibitors of SL metabolism. Lipidomic analysis revealed a general ceramide deficit and a profound upswing in levels of sphingosine 1-phosphate (S1P) and ceramide 1-phosphate (C1P) in HL-60/dnr cells versus parental and HL-60/Ara-C cells. Both chemotherapyselected cells also exhibited comprehensive upregulations in mitochondrial biogenesis consistent with heightened reliance on oxidative phosphorylation, a property that was partially reversed by exposure to AC and SPHK1 inhibitors and that supports a role for the phosphorylation system in resistance. In summary, dnr and Ara-C selection pressure induces acute reductions in ceramide levels and large increases in S1P and C1P, concomitant with cell resilience bolstered by enhanced mitochondrial remodeling. Thus, strategic control of ceramide metabolism and further research to define mitochondrial perturbations that accompany the drug-resistant phenotype offer new opportunities for developing therapies that regulate cancer growth. | Versión del editor: | 10.1194/jlr.RA119000251 | URI: | http://hdl.handle.net/10261/189423 | DOI: | 10.1194/jlr.RA119000251 |
Aparece en las colecciones: | (IQAC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergeticsin.pdf | Artículo principal | 1,64 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
17
checked on 19-mar-2024
SCOPUSTM
Citations
18
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
19
checked on 23-feb-2024
Page view(s)
228
checked on 23-abr-2024
Download(s)
186
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.